EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer

Wei Zhang, Jiping Li, Liling Yue, Chenfeng Ji

Pharmaceutics · 27.10.2024 · 16 (11) · 1382

DOI: 10.3390/pharmaceutics16111382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.10.2024. Verfasst von Wei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center for Medicine, College of Pharmacy, Harbin University of Commerce, Harbin 150028, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qiqihar Science and Technology Program Joint Guidance Project, Scientific Research Project of Heilongjiang Provincial Health Commission, Scientific Research Project of Heilongjiang Provincial Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Breast cancer, a leading health threat affecting millions worldwide, requires effective therapeutic interventions. Celastrol (CEL), despite its antitumor potential, is limited by poor solubility and stability. This study aimed to enhance CEL’s efficacy by encapsulating it within glycyrrhizic acid (GA)-modified lipid calcium carbonate (LCC) nanoparticles for targeted breast cancer therapy.

Methods

The 4T1 mouse breast cancer cells were used for the study. GA-LCC-CEL nanoparticles were prepared using a gas diffusion method and a thin-film dispersion method. GA-LCC-CEL were characterized using the zeta-potential, dynamic light scattering and transmission electron microscope (TEM). The in vitro release behavior of nanoparticles was assessed using the in vitro dialysis diffusion method. Cellular uptake was examined using flow cytometry and confocal microscopy. Intracellular ROS and Rhodamine 123 levels were observed under fluorescence microscopy. MTT and colony formation assays assessed cytotoxicity and proliferation, and apoptosis was analyzed by Annexin V-FITC/PI staining. Wound healing and transwell assays evaluated migration, and Western blotting confirmed protein expression changes related to apoptosis and migration.

Results

GA-LCC-CEL nanoparticles displayed a well-defined core-shell structure with a uniform size distribution. They showed enhanced anti-proliferative and pro-apoptotic effects against 4T1 cells and significantly reduced breast cancer cell invasion and migration. Additionally, GA-LCC-CEL modulated epithelial-mesenchymal transition (EMT) protein expression, downregulating Snail and ZEB1, and upregulating E-cadherin.

Conclusions

GA-LCC-CEL nanoparticles represent a promising targeted drug delivery approach for breast cancer, enhancing CEL’s antitumor efficacy and potentially inhibiting cancer progression by modulating EMT-related proteins.

Schlagwörter

Stichwörter der Autor:innen

calcium carbonatecancer treatmentcelastrollipid coatednanoparticles

Autor:innen und Institutionen

  • Engineering Research Center for Medicine, College of Pharmacy, Harbin University of Commerce, Harbin 150028, China.
  • School of Public Health, Qiqihar Medical University, Qiqihar 161006, China.
  • Office of Academic Research, Qiqihar Medical University, Qiqihar 161006, China.

Förderung

  • Qiqihar Science and Technology Program Joint Guidance Project
  • Scientific Research Project of Heilongjiang Provincial Health Commission
  • Scientific Research Project of Heilongjiang Provincial Education Department

Zitieren

APA

Zhang, W., Li, J., Yue, L., & Ji, C. (2024). Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer. Pharmaceutics, 16(11), 1382. https://doi.org/10.3390/pharmaceutics16111382

Vancouver

Zhang W, Li J, Yue L, Ji C. Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer. Pharmaceutics. 2024;16(11):1382. doi:10.3390/pharmaceutics16111382

BibTeX
@article{Zhang2024,
  author = {Zhang, Wei and Li, Jiping and Yue, Liling and Ji, Chenfeng},
  title = {Targeted Delivery of Celastrol by GA-Modified Liposomal Calcium Carbonate Nanoparticles to Enhance Antitumor Efficacy Against Breast Cancer},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1382},
  doi = {10.3390/pharmaceutics16111382}
}
Kostenlos starten →